AptarGroup, Inc.'s SEC filings document operating results, governance matters and capital-structure activity for a NYSE-listed maker of drug delivery and consumer-product dispensing technologies. Form 8-K reports furnish quarterly and annual results, segment commentary for Pharma, Beauty and Closures, shareholder returns and material events tied to the company's operations.
The filing record also includes proxy materials and annual meeting vote results covering director elections, advisory compensation matters and stockholder voting items. Capital disclosures include common stock registered under the Exchange Act, shelf-registration activity and completed debt financing, including the 4.750% Senior Notes due 2031 issued under an indenture.
APTARGROUP, INC. director George L. Fotiades received a grant of 151 shares of Common Stock on July 16, 2026. The shares were acquired at $0.00 per share as an award, bringing his directly held position to 6,446 shares following the transaction.
Kampouri Monnas Giovanna reported acquisition or exercise transactions in this Form 4 filing.
APTARGROUP, INC. director Giovanna Kampouri Monnas received an equity award of 151 shares of Common Stock on 2026-07-16 at no cost, increasing her directly held stake to 10,128 shares.
AptarGroup, Inc. director Isabel Marey-Semper received a grant of 151 shares of Common Stock on 2026-07-16, reported as a grant/award acquisition at a per-share price of $0.0000. Following this award, she directly owns 9,821 shares of AptarGroup common stock.
Candace S. Matthews, a director of AptarGroup, Inc., reported a grant/award acquisition of 226 shares of Common Stock on 2026-07-16 at a stated price of $0.00 per share. Following this award, she directly holds 8,101 shares of Common Stock. The Rule 10b5-1 checkbox was not selected.
APTARGROUP, INC. director Ralf K. Wunderlich received a grant of 151 shares of Common Stock on July 16, 2026, reported at $0.0000 per share as a grant/award acquisition. After this award, he directly owns 18,690 shares of AptarGroup common stock. The transaction was not reported under a Rule 10b5-1 trading plan.
APTARGROUP, INC. director B Craig Owens reported a grant/award acquisition of 151 shares of common stock on 2026-07-16, at a reported per-share price of $0.0000. Following this equity award, his directly owned holdings increased to 11,233.592 shares of common stock.
APTARGROUP, INC. director Sarah JS Glickman reported a grant, award, or other acquisition of 151 shares of Common Stock on 2026-07-16. The shares were reported at a per-share price of $0.0000, indicating a no-cash stock award. Following this transaction, she directly holds 4,553 shares of AptarGroup common stock.
Xing Julie reported acquisition or exercise transactions in this Form 4 filing.
Director Julie Xing of AptarGroup, Inc. reported receiving a grant of 151 shares of Common Stock on 2026-07-16 at $0.00 per share. Following this award, she directly owns 5,242 shares of AptarGroup Common Stock.